Showing results (161-170 of 182) with videos related to
Sort By:
Pageof 19
Journal of Viral Hepatitis|April 1, 2018
Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programmeP Godoy, G Carmona, S Manzanares, et al.Cureus|August 19, 2024
The Evolving Use of Gold Nanoparticles as a Possible Reversal Agent for the Symptoms of Neurodegenerative Diseases: A Narrative ReviewAlan D Kaye, Kelly R Sala, Drew Dethloff, et al.Physics in Medicine and Biology|January 24, 2017
A phenomenological relative biological effectiveness approach for proton therapy based on an improved description of the mixed radiation fieldA Mairani, I Dokic, G Magro, et al.Neuroimage|October 30, 2012
Functional connectivity in obesity during reward processingI García-García, M A Jurado, M Garolera, et al.Cureus|September 20, 2024
The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative ReviewAlan D Kaye, Kelly R Sala, Brennan M Abbott, et al.Cureus|December 26, 2024
Transcutaneous Electrical Nerve Stimulation for Prevention and Treatment of Post-Herpetic Neuralgia: A Narrative ReviewAlan D Kaye, Rahib K Islam, Victoria T Tong, et al.Journal of Food Protection|October 12, 2013
Norovirus: a growing cause of gastroenteritis in catalonia (Spain)?A Martínez, N Torner, S Broner, et al.Physics in Medicine and Biology|May 21, 2016
Biologically optimized helium ion plans: calculation approach and its in vitro validationA Mairani, I Dokic, G Magro, et al.Emerging Infectious Diseases|October 20, 2020
Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013Josep Alvarez, Pere Godoy, Pedro Plans-Rubio, et al.Oncology|October 2, 2004
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-upS Barni, E Piazza, L Frontini, et al.Pageof 19